Trial Profile
Clinical Trials Insight: 700038727
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Nov 2008
Price :
$35
*
At a glance
- Drugs Lapuleucel T (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 06 Nov 2008 New trial record.